Improved aza-bridged-bicyclic amino acid derivatives as a4 integrin antagonists

Details for Australian Patent Application No. 2004285025 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Dyatkin, Alexey B.; Miskowski, Tamara A.; He, Wei; Gong, Yong

Agent Shelston IP

Pub. Number AU-A-2004285025

PCT Pub. Number WO2005/042529

Priority 60/516,574 31.10.03 US

Filing date 28 October 2004

Wipo publication date 12 May 2005

International Classifications

C07D 451/14 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 453/06 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042529 Priority application(s): WO2005/042529

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285026-Carton with dispensing feature for cans

2004285022-N-substituted benzene sulfonamides